EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C28H32Cl2N4O6S2 |
| Net Charge | 0 |
| Average Mass | 655.626 |
| Monoisotopic Mass | 654.11403 |
| SMILES | CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1 |
| InChI | InChI=1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1 |
| InChIKey | IVYQPSHHYIAUFO-VXKWHMMOSA-N |
| Roles Classification |
|---|
| Biological Role: | TRPV4 agonist An agonist at the transient receptor potential vanilloid 4 (TRPV4). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| GSK1016790A (CHEBI:140524) has role TRPV4 agonist (CHEBI:140061) |
| GSK1016790A (CHEBI:140524) is a N-acylpiperazine (CHEBI:46844) |
| GSK1016790A (CHEBI:140524) is a 1-benzothiophenes (CHEBI:38836) |
| GSK1016790A (CHEBI:140524) is a aromatic primary alcohol (CHEBI:33857) |
| GSK1016790A (CHEBI:140524) is a dichlorobenzene (CHEBI:23697) |
| GSK1016790A (CHEBI:140524) is a sulfonamide (CHEBI:35358) |
| GSK1016790A (CHEBI:140524) is a tertiary carboxamide (CHEBI:140326) |
| IUPAC Name |
|---|
| N-[(2S)-1-(4-{N-[(2,4-dichlorophenyl)sulfonyl]-L-seryl}piperazin-1-yl)-4-methyl-1-oxopentan-2-yl]-1-benzothiophene-2-carboxamide |
| Synonyms | Source |
|---|---|
| N-[(2S)-1-{4-[(2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl]piperazin-1-yl}-4-methyl-1-oxopentan-2-yl]-1-benzothiophene-2-carboxamide | IUPAC |
| GSK 1016790A | ChEBI |
| GSK-1016790A | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 329799716 | PubChem Compound |
| Registry Numbers | Sources |
|---|---|
| Reaxys:12914325 | Reaxys |
| Citations |
|---|